The Japanese Biochemical Society/The Molecular Biology Society of Japan

ConBio2017

ConBio2017

Dec 6, 2017 - Dec 9, 2017
Kobe Port Island(Kobe International Conference Center, Kobe Portopia Hotel, Kobe International Exhibition Hall, The Kobe Chamber of Commerce and Industry)

[2P-0325] Mode of action that specifies therapeutic efficacy of α9β1 blocking monoclonal antibodies.

〇Mikage Otani1, Norihisa Nishimichi2, Masumi Ito2, Masao Yoshizumi4, Yasuyuki Yokosaki2,3 (1.Cell-Matrix Lab., Grad. Sch. of Med., Univ. of Hiroshima, 2.Cell-Matrix Lab., Health Admin., Hiroshima Univ., 3.Clin. Gene., Hiroshima Univ. Hosp., 4.Dept. of Cardiovasc Physiol and Med., Grad. Sch. of Med., Univ. of Hiroshima)

integrin、mode of action、antibody

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password